- Home
- AVTE vs NTRB Comparison
AVTE vs NTRB Comparison
Compare AVTE & NTRB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AVTE
- NTRB
- Stock Information
- Founded
- AVTE 2018
- NTRB 2016
- Country
- AVTE United States
- NTRB United States
- Employees
- AVTE N/A
- NTRB N/A
- Industry
- AVTE Biotechnology: Pharmaceutical Preparations
- NTRB Industrial Specialties
- Sector
- AVTE Health Care
- NTRB Health Care
- Exchange
- AVTE Nasdaq
- NTRB Nasdaq
- Market Cap
- AVTE 72.5M
- NTRB N/A
- IPO Year
- AVTE 2021
- NTRB N/A
- Fundamental
- Price
- AVTE $2.51
- NTRB $6.13
- Analyst Decision
- AVTE Hold
- NTRB Buy
- Analyst Count
- AVTE 7
- NTRB 1
- Target Price
- AVTE $11.75
- NTRB $13.00
- AVG Volume (30 Days)
- AVTE 62.3K
- NTRB 20.8K
- Earning Date
- AVTE 03-27-2025
- NTRB 04-30-2025
- Dividend Yield
- AVTE N/A
- NTRB N/A
- EPS Growth
- AVTE N/A
- NTRB N/A
- EPS
- AVTE N/A
- NTRB N/A
- Revenue
- AVTE N/A
- NTRB $2,021,771.00
- Revenue This Year
- AVTE N/A
- NTRB $7.95
- Revenue Next Year
- AVTE N/A
- NTRB $538.25
- P/E Ratio
- AVTE N/A
- NTRB N/A
- Revenue Growth
- AVTE N/A
- NTRB N/A
- 52 Week Low
- AVTE $1.25
- NTRB $3.20
- 52 Week High
- AVTE $32.42
- NTRB $11.78
- Technical
- Relative Strength Index (RSI)
- AVTE 52.00
- NTRB 40.86
- Support Level
- AVTE $2.44
- NTRB $6.37
- Resistance Level
- AVTE $2.56
- NTRB $6.70
- Average True Range (ATR)
- AVTE 0.09
- NTRB 0.31
- MACD
- AVTE 0.00
- NTRB -0.03
- Stochastic Oscillator
- AVTE 77.14
- NTRB 13.99
About AVTE Aerovate Therapeutics Inc.
Aerovate Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing drugs that improve the lives of patients with rare cardiopulmonary disease. The initial focus of the company is on advancing AV-101, a dry powder inhaled formulation of imatinib for the treatment of pulmonary arterial hypertension.